CA2558583C - Polymer-based compositions and conjugates of hiv entry inhibitors - Google Patents
Polymer-based compositions and conjugates of hiv entry inhibitors Download PDFInfo
- Publication number
- CA2558583C CA2558583C CA2558583A CA2558583A CA2558583C CA 2558583 C CA2558583 C CA 2558583C CA 2558583 A CA2558583 A CA 2558583A CA 2558583 A CA2558583 A CA 2558583A CA 2558583 C CA2558583 C CA 2558583C
- Authority
- CA
- Canada
- Prior art keywords
- conjugate
- polymer
- daltons
- peg
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
- C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
- C07K14/16—HIV-1 ; HIV-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
- C08G63/12—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from polycarboxylic acids and polyhydroxy compounds
- C08G63/46—Polyesters chemically modified by esterification
- C08G63/48—Polyesters chemically modified by esterification by unsaturated higher fatty oils or their acids; by resin acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Polymers & Plastics (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55314604P | 2004-03-15 | 2004-03-15 | |
| US60/553,146 | 2004-03-15 | ||
| PCT/US2005/008632 WO2005089805A2 (en) | 2004-03-15 | 2005-03-15 | Polymer-based compositions and conjugates of hiv entry inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2558583A1 CA2558583A1 (en) | 2005-09-29 |
| CA2558583C true CA2558583C (en) | 2013-07-09 |
Family
ID=34994420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2558583A Expired - Lifetime CA2558583C (en) | 2004-03-15 | 2005-03-15 | Polymer-based compositions and conjugates of hiv entry inhibitors |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9446139B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1725262B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4805911B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101276422B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101132812A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005222641B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2558583C (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA06010505A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005089805A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7432331B2 (en) * | 2002-12-31 | 2008-10-07 | Nektar Therapeutics Al, Corporation | Hydrolytically stable maleimide-terminated polymers |
| ATE444984T1 (de) * | 2002-12-31 | 2009-10-15 | Nektar Therapeutics Al Corp | Hydrolysestabile maleimidendgruppen-enthaltende polymere |
| RU2006128593A (ru) * | 2004-01-07 | 2008-02-20 | Тримерис, Инк. (Us) | Синтетические пептиды, производные области hr2 белка gp41 вич, и их применение в терапии для ингибирования проникновения вируса иммунодефицита человека |
| DE102004031258A1 (de) * | 2004-06-29 | 2006-02-09 | Jennissen, Herbert P., Prof. Dr. | Proteinhybride mit polyhydroxyaromatischen Aminosäure-Epitopen |
| US8273339B2 (en) | 2005-04-12 | 2012-09-25 | Nektar Therapeutics | Polymer-based compositions and conjugates of antimicrobial agents |
| ATE537183T1 (de) | 2006-02-02 | 2011-12-15 | Trimeris Inc | Hiv-fusionshemmerpeptide mit verbesserten biologischen eigenschaften |
| US7462627B2 (en) * | 2006-02-09 | 2008-12-09 | Enzon Pharmaceuticals, Inc. | Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers |
| US7671067B2 (en) * | 2006-02-09 | 2010-03-02 | Enzon Pharmaceuticals, Inc. | Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamtothecin |
| EP2319542B1 (en) | 2006-02-21 | 2018-03-21 | Nektar Therapeutics | Segmented degradable polymers and conjugates made therefrom |
| WO2007140282A1 (en) * | 2006-05-24 | 2007-12-06 | Peg Biosciences | Peg linker compounds and biologically active conjugates thereof |
| CN101534847A (zh) | 2006-08-04 | 2009-09-16 | 普罗龙药品公司 | 修饰型促红细胞生成素 |
| MX2009008549A (es) * | 2007-02-09 | 2009-08-18 | Enzon Pharmaceuticals Inc | Tratamiento de canceres resistentes o refractarios con conjugados polimericos de brazos multiples de 7-etil-10-hidroxicamptotecina. |
| US20140011964A1 (en) | 2007-02-28 | 2014-01-09 | Serina Therapeutics, Inc. | Activated Polyoxazolines and Conjugates and Compositions Comprising the Same |
| CN106046370A (zh) * | 2007-02-28 | 2016-10-26 | 塞瑞纳治疗公司 | 聚噁唑啉poz化合物、合成其的方法、以及靶分子‑poz偶联物 |
| CN101678125A (zh) * | 2007-04-03 | 2010-03-24 | 特里梅里斯公司 | 用于递送抗病毒肽治疗剂的新制剂 |
| CA2700354A1 (en) * | 2007-09-25 | 2009-04-02 | Trimeris, Inc. | Novel methods of synthesis for therapeutic antiviral peptides |
| TW201010732A (en) * | 2008-08-29 | 2010-03-16 | Enzon Pharmaceuticals Inc | Method of treating RAS associated cancer |
| US20100098654A1 (en) * | 2008-10-21 | 2010-04-22 | Fabio Pastorino | Treatment of neuroblastoma with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
| CA2780645C (en) * | 2009-11-18 | 2018-01-16 | Nektar Therapeutics | Salt form of a multi-arm polymer-drug conjugate |
| WO2011084458A2 (en) * | 2009-12-15 | 2011-07-14 | The Johns Hopkins University | Polymer-based compositions and methods for treatment of peritoneal disorders |
| US20110295365A1 (en) * | 2010-05-28 | 2011-12-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Anti-viral compositions and methods for administration |
| JP6226958B2 (ja) * | 2012-04-18 | 2017-11-08 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッドSiemens Healthcare Diagnostics Inc. | コンジュゲート試薬を製造するための化合物および方法 |
| CN104109240A (zh) * | 2014-07-13 | 2014-10-22 | 成都市绿科华通科技有限公司 | 一种可作为药物载体的多孔聚乙二醇的制备方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69233480T2 (de) | 1991-02-08 | 2006-01-05 | Progenics Pharmaceuticals, Inc. | CD4-gamma2- und CD4-IgG2-Chimären |
| US5446090A (en) | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
| US5932462A (en) * | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| US5792462A (en) * | 1995-05-23 | 1998-08-11 | University Of North Carolina At Chapel Hill | Alphavirus RNA replicon systems |
| CA2323048C (en) | 1998-03-12 | 2006-10-10 | Shearwater Polymers, Inc. | Poly(ethylene glycol) derivatives with proximal reactive groups |
| US6656906B1 (en) * | 1998-05-20 | 2003-12-02 | Trimeris, Inc. | Hybrid polypeptides with enhanced pharmacokinetic properties |
| US20040228869A1 (en) | 1998-12-16 | 2004-11-18 | Progenics Pharmaceuticals, Inc. | Synergistic inhibition of HIV-1 fusion and attachment, compositions and antibodies thereto |
| US6469136B1 (en) | 1999-07-07 | 2002-10-22 | Trimeris, Inc. | Methods and composition for peptide synthesis |
| US6541020B1 (en) | 1999-07-09 | 2003-04-01 | Trimeris, Inc. | Methods and compositions for administration of therapeutic reagents |
| US6413507B1 (en) * | 1999-12-23 | 2002-07-02 | Shearwater Corporation | Hydrolytically degradable carbamate derivatives of poly (ethylene glycol) |
| US6602498B2 (en) * | 2000-02-22 | 2003-08-05 | Shearwater Corporation | N-maleimidyl polymer derivatives |
| WO2001064710A2 (en) | 2000-02-29 | 2001-09-07 | Progenics Pharmaceuticals, Inc. | Sulfated ccr5 peptides for hiv-1 infection |
| BR0312889A (pt) | 2002-07-24 | 2005-06-14 | Hoffmann La Roche | Polipeptìdeo t20 peguilado |
| NZ537493A (en) | 2002-07-24 | 2007-05-31 | Hoffmann La Roche | Pegylated T1249 polypeptide |
| CN100337689C (zh) * | 2002-07-24 | 2007-09-19 | 弗·哈夫曼-拉罗切有限公司 | 聚亚烷基二醇酸加合物 |
| JP4764630B2 (ja) * | 2002-09-09 | 2011-09-07 | ネクター セラピューティックス | 水溶性ポリマーアルカナール |
| US7556813B2 (en) | 2002-09-27 | 2009-07-07 | Trimeris, Inc. | Antiviral peptide-polymer conjugate comprising a polymer covalently attached to two or more synthetic HIV gp41 HR1 and/or HR2 peptides |
| WO2004060977A1 (en) | 2002-12-30 | 2004-07-22 | Nektar Therapeutics Al, Corporation | Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles |
| WO2004060967A1 (en) | 2002-12-31 | 2004-07-22 | Nektar Therapeutics Al, Corporation | Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof |
| KR101031206B1 (ko) * | 2002-12-31 | 2011-04-27 | 넥타르 테라퓨틱스 | 말레암산 중합체 유도체 및 이의 바이오컨쥬게이트 |
| US7910661B2 (en) | 2003-01-06 | 2011-03-22 | Nektar Therapeutics | Thiol-selective water-soluble polymer derivatives |
| EP1596887B1 (en) * | 2003-02-26 | 2022-03-23 | Nektar Therapeutics | Polymer-factor viii moiety conjugates |
| PT2644206T (pt) | 2003-05-23 | 2019-07-10 | Nektar Therapeutics | Derivados de peg contendo duas cadeias de peg |
| CA2556032A1 (en) * | 2004-03-15 | 2005-09-29 | Trimeris, Inc. | Site-specific chemical modification of hiv gp41-derived peptides |
-
2005
- 2005-03-15 EP EP05725666.1A patent/EP1725262B1/en not_active Expired - Lifetime
- 2005-03-15 CA CA2558583A patent/CA2558583C/en not_active Expired - Lifetime
- 2005-03-15 JP JP2007504041A patent/JP4805911B2/ja not_active Expired - Fee Related
- 2005-03-15 AU AU2005222641A patent/AU2005222641B2/en not_active Ceased
- 2005-03-15 MX MXPA06010505A patent/MXPA06010505A/es active IP Right Grant
- 2005-03-15 US US11/082,229 patent/US9446139B2/en not_active Expired - Fee Related
- 2005-03-15 WO PCT/US2005/008632 patent/WO2005089805A2/en not_active Ceased
- 2005-03-15 KR KR1020067019107A patent/KR101276422B1/ko not_active Expired - Fee Related
- 2005-03-15 CN CNA2005800082104A patent/CN101132812A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1725262B1 (en) | 2021-05-26 |
| CA2558583A1 (en) | 2005-09-29 |
| WO2005089805A3 (en) | 2007-07-19 |
| WO2005089805A2 (en) | 2005-09-29 |
| JP4805911B2 (ja) | 2011-11-02 |
| AU2005222641A1 (en) | 2005-09-29 |
| EP1725262A2 (en) | 2006-11-29 |
| KR101276422B1 (ko) | 2013-06-19 |
| MXPA06010505A (es) | 2006-12-19 |
| JP2007529539A (ja) | 2007-10-25 |
| KR20060130225A (ko) | 2006-12-18 |
| US20050226843A1 (en) | 2005-10-13 |
| AU2005222641B2 (en) | 2011-04-07 |
| CN101132812A (zh) | 2008-02-27 |
| US9446139B2 (en) | 2016-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1725262B1 (en) | Polymer-based compositions and conjugates of hiv entry inhibitors | |
| AU2022268401B2 (en) | Conjugates of an IL-2 moiety and a polymer | |
| EP1885403B1 (en) | Poly(ethyleneglycol) conjugates of Lysostaphin | |
| AU2016228555B2 (en) | Conjugates of an IL-7 moiety and a polymer | |
| CA2942571A1 (en) | Conjugates of an il-15 moiety and a polymer | |
| WO2013020079A2 (en) | Conjugates of an il-11 moiety and a polymer | |
| AU2009246851B2 (en) | Conjugates of a cholinesterase moiety and a polymer | |
| HK40053166A (en) | Conjugates of an il-2 moiety and a polymer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| H11 | Ip right ceased following rejected request for revival |
Free format text: ST27 STATUS EVENT CODE: T-6-6-H10-H11-H101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TIME LIMIT FOR REVERSAL EXPIRED Effective date: 20240916 |